BioSpace News Archive

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that the European Patent Office issued European Patent No. 3242676 to the Company on October 4, 2023.

Bausch + Lomb Corporation today announced one podium presentation and four poster presentations during the American Academy of Optometry (AAOpt) annual meeting, which will take place in New Orleans Oct. 11-14, 2023.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced financial results for the first quarter of fiscal year 2024, which ended August 31, 2023.

Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIRO Analytical AG , an innovative provider of fast, compact Quantum Cascade Laser (QCL)-based multi-gas analyzers for simultaneous, highest-precision monitoring of up to 10 trace gases.

SwanBio Therapeutics today announced it has begun the second dose-escalation cohort of its first interventional clinical study, PROPEL.

Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that is developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced that Beyond Cancer, Ltd. will present two proffered posters at the upcoming American Association for Cancer Research-National Cancer Institute-European Organisation for Research and Treatment of Cancer.

Avertix Medical, Inc., formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and BIOS Acquisition Corporation, a special purpose acquisition company, announced that the two companies have mutually agreed to terminate their proposed business combination.

Actinium Pharmaceuticals, Inc. announced the National Institutes of Health (NIH) awarded Actinium a Small Business Technology Transfer grant extension to support its clinical collaboration with Memorial Sloan Kettering Cancer Center (MSK) to study Iomab-ACT.

Pathnostics announced that its advanced test for urinary tract infections has gained approval from the New York State Department of Health.

MyMD Pharmaceuticals, Inc. ® announced that it plans to share information on the Company and its product pipeline, including an update on recent positive phase 2 study results for MYMD-1 in sarcopenia, at the upcoming BioFuture 2023 Meeting.